Search Results - Noboru Yamamoto

Emerging PD-1/PD-L1 targeting immunotherapy in non-small cell lung cancer: Current status and future perspective in Japan, US, EU, and China by Takaaki Mizuno, Yuki Katsuya, Jun Sato, Takafumi Koyama, Toshio Shimizu, Noboru Yamamoto, Noboru Yamamoto

Get full text

Mission of the National Cancer Center Hospital in Japan to promote clinical trials for precision medicine by Kazuaki Shimada, Kenichi Nakamura, Noboru Yamamoto

Get full text

Clonal Hematopoiesis From Next Generation Sequencing of Plasma From a Patient With Lung Adenocarcinoma: A Case Report by Munehiro Ito, Yutaka Fujiwara, Yutaka Fujiwara, Yutaka Fujiwara, Takashi Kubo, Hiromichi Matsushita, Tadashi Kumamoto, Tatsuya Suzuki, Kuniko Sunami, Noboru Yamamoto, Noboru Yamamoto, Takashi Kohno, Takashi Kohno

Get full text

Regional diversity in drug-induced lung diseases among the USA, European Union, and Japan by Jun Sato, Ryo Sadachi, Takafumi Koyama, Yuki Katsuya, Mao Okada, Noboru Yamamoto

Get full text

Precise evaluation of time-varying quadrupole field errors through closed-orbit measurements in the J-PARC main ring by Takashi Asami, Hideaki Hotchi, Susumu Igarashi, Tadashi Koseki, Yoichi Sato, Noboru Yamamoto, Takaaki Yasui

Get full text

Prevalence of psychological distress, quality of life, and satisfaction among patients and family members following comprehensive genomic profiling testing: Protocol of the Quality... by Makoto Nishino, Maiko Fujimori, Takafumi Koyama, Makoto Hirata, Noriko Tanabe, Toshio Shimizu, Noboru Yamamoto, Yosuke Uchitomi

Get full text

The evolution of cancer genomic medicine in Japan and the role of the National Cancer Center Japan by Teruhiko Yoshida, Yasushi Yatabe, Ken Kato, Genichiro Ishii, Akinobu Hamada, Hiroyuki Mano, Kuniko Sunami, Noboru Yamamoto, Takashi Kohno

Get full text

Effects of Sarcopenia on the Outcomes and Safety of Chemoradiotherapy Followed by Durvalumab for the Treatment of Patients With Locally Advanced Non‐Small Cell Lung Cancer by Kentaro Tamura, Hidehito Horinouchi, Mototaka Miyake, Ken Masuda, Yuki Shinno, Yusuke Okuma, Tatsuya Yoshida, Noboru Yamamoto, Yasushi Goto

Get full text

Erlotinib with or without bevacizumab as a first‐line therapy for patients with advanced nonsquamous epidermal growth factor receptor‐positive non‐small cell lung cancer: Explorato... by Yukio Hosomi, Takashi Seto, Makoto Nishio, Koichi Goto, Noboru Yamamoto, Isamu Okamoto, Kosei Tajima, Yusuke Kajihara, Nobuyuki Yamamoto

Get full text

Safety, tolerability, pharmacokinetics, and antitumor activity of adavosertib in Japanese patients with advanced solid tumors: A phase I, open-label study by Shunsuke Kondo, Yuki Katsuya, Kan Yonemori, Keiko Komuro, Masatoshi Sugeno, Toshio Kawata, Dana Ghiorghiu, Didier Meulendijks, Noboru Yamamoto

Get full text

Phase 1 study of telisotuzumab vedotin in Japanese patients with advanced solid tumors by Yutaka Fujiwara, Hirotsugu Kenmotsu, Noboru Yamamoto, Toshio Shimizu, Kan Yonemori, Christopher Ocampo, Apurvasena Parikh, Sumiko Okubo, Kazuteru Fukasawa, Haruyasu Murakami

Get full text

Merestinib monotherapy or in combination for japanese patients with advanced and/or metastatic cancer: A phase 1 study by Toshihiko Doi, Noboru Yamamoto, Yoichi Naito, Yasutoshi Kuboki, Takafumi Koyama, Yongzhe Piao, Naoto Tsujimoto, Hiroya Asou, Koichi Inoue, Shunsuke Kondo

Get full text

Mixed response to osimertinib and the beneficial effects of additional local therapy by Yuki Shinno, Yasushi Goto, Jun Sato, Ryo Morita, Yuji Matsumoto, Shuji Murakami, Shintaro Kanda, Hidehito Horinouchi, Yutaka Fujiwara, Noboru Yamamoto, Yuichiro Ohe

Get full text

Feasibility of genomic profiling with next-generation sequencing using specimens obtained by image-guided percutaneous needle biopsy by Miyuki Sone, Yasuaki Arai, Shunsuke Sugawara, Takatoshi Kubo, Chihiro Itou, Tetsuya Hasegawa, Noriyuki Umakoshi, Noboru Yamamoto, Kumiko Sunami, Nobuyoshi Hiraoka, Takashi Kubo

Get full text

Successful Treatment of HER2 V659E Mutation‐Positive Lung Adenocarcinoma With Trastuzumab Deruxtecan: A Case Report by Mariko Nishihara, Yuki Shinno, Yoshihiro Masui, Ken Masuda, Yuji Matsumoto, Yusuke Okuma, Tatsuya Yoshida, Yasushi Goto, Hidehito Horinouchi, Noboru Yamamoto, Yuichiro Ohe

Get full text

Number of metastatic organs negatively affects the treatment sequence in patients with EGFR‐TKI failure by Takaaki Mizuno, Hidehito Horinouchi, Sho Watanabe, Jun Sato, Ryo Morita, Shuji Murakami, Yasushi Goto, Shintaro Kanda, Yutaka Fujiwara, Noboru Yamamoto, Yuichiro Ohe

Get full text

Malignant pleural effusion as a predictor of the efficacy of anti‐PD‐1 antibody in patients with non‐small cell lung cancer by Ryota Shibaki, Shuji Murakami, Yuki Shinno, Yuji Matsumoto, Yasushi Goto, Shintaro Kanda, Hidehito Horinouchi, Yutaka Fujiwara, Noriko Motoi, Noboru Yamamoto, Yuichiro Ohe

Get full text

Phase I study of the safety and clinical activity of the interleukin-8 inhibitor AMY109 combined with atezolizumab in patients with advanced solid cancers by Yasutoshi Kuboki, Masafumi Ikeda, Shigehisa Kitano, Takafumi Koyama, Noboru Yamamoto, Yuki Yamaguchi, Yuki Nakagawa, Takaaki Ishida, Hidenori Mizugaki, Takatsugu Narikiyo, Ryoko Takubo, Chika Ogami, Mayuko Sekiya

Get full text

Schlafen 11 Expression in Patients With Small Cell Lung Cancer and Its Association With Clinical Outcomes by Ken Masuda, Tatsuya Yoshida, Noriko Motoi, Yuki Shinno, Yuji Matsumoto, Yusuke Okuma, Yasushi Goto, Hidehito Horinouchi, Noboru Yamamoto, Shun‐ichi Watanabe, Tomoaki Hoshino, Yasushi Yatabe, Yuichiro Ohe

Get full text

Tolerability and efficacy of durvalumab, either as monotherapy or in combination with tremelimumab, in patients from Asia with advanced biliary tract, esophageal, or head‐and‐neck... by Yuichiro Doki, Makoto Ueno, Chih‐Hung Hsu, Do‐Youn Oh, Keunchil Park, Noboru Yamamoto, Tatsuya Ioka, Hiroki Hara, Manabu Hayama, Masahiro Nii, Keiko Komuro, Mariko Sugimoto, Makoto Tahara

Get full text